https://canceradvocacy.org/wp-content/uploads/JAMA-Article.jpg
545
1030
actualizedevs
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
actualizedevs2013-07-31 10:00:572020-11-30 12:57:14The Definition of “Cancer”: JAMA Opinion Piece Triggers Medical, Scientific, and Policy DebateNCCS is now Cancer Nation. Find out more about our next chapter. Join Us
News
https://canceradvocacy.org/wp-content/uploads/JAMA-Article.jpg
545
1030
actualizedevs
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
actualizedevs2013-07-31 10:00:572020-11-30 12:57:14The Definition of “Cancer”: JAMA Opinion Piece Triggers Medical, Scientific, and Policy DebateNCCS Comments on Quality Measures for PPS-Exempt Cancer Hospitals
NCCS filed comments in support of proposed cancer care quality measures that will be utilized to assess the cancer care provided by…
Washington Post Wonkblog Discusses Myriad and BRCA Tests
The United States Supreme Court ruled unanimously on June 13, 2013, that human genes cannot be patented. In the case of Association…
Clinical Trials System Evaluation and IOM Workshop Summary
In the Sunday, July 14, New York Times, Clifton Leaf offered a critical evaluation of clinical trials. In letters to the editor published…
The ACA: Health Affairs Explains Upcoming Implementation and Exchanges
October 1, 2013 is rapidly approaching. That’s the beginning of open enrollment for insurance through state exchanges created to…
Clifton Leaf Opinion Piece in NY Times “Do Clinical Trials Work?”
Clifton Leaf, a cancer survivor and the author of "The Truth in Small Doses: Why We're Losing the War on Cancer - and How to Win It",…
NIH Appropriations: Senate Bill Includes an Increase in Funding Above FY 2013
The Senate Appropriations Committee approved a fiscal year 2014 funding bill by a party-line vote of 16 to 14 on July 11, 2013. In…
Shelley Fuld Nasso of NCCS Is Panelist at FDA Lung Cancer Meeting
Shelley Fuld Nasso, NCCS Senior Director of Policy, was a panelist at the June 28, 2013, Food and Drug Administration (FDA) meeting…

